[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Narcolepsy Therapeutics Market Survey and Trend Research 2018

September 2018 | 70 pages | ID: GC25F2CF060EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., BIOPROJET, BIOPROJET, Shire, Ligand Pharmaceuticals, Inc. etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Narcolepsy Therapeutics Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NARCOLEPSY THERAPEUTICS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Addrenex Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Teva Pharmaceutical Industries Ltd. (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Jazz Pharmaceuticals PLC (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Graymark Healthcare, Inc. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 BIOPROJET (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 BIOPROJET (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Shire (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Ligand Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Narcolepsy Therapeutics Market 2012-2017, by Type, in USD Million
Table Global Narcolepsy Therapeutics Market Forecast 2018-2023, by Type, in USD Million
Table Addrenex Pharmaceuticals, Inc. Overview List
Table Narcolepsy Therapeutics Business Operation of Addrenex Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. Overview List
Table Narcolepsy Therapeutics Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Cost, Gross Margin)
Table Jazz Pharmaceuticals PLC Overview List
Table Narcolepsy Therapeutics Business Operation of Jazz Pharmaceuticals PLC (Sales Revenue, Cost, Gross Margin)
Table Graymark Healthcare, Inc. Overview List
Table Narcolepsy Therapeutics Business Operation of Graymark Healthcare, Inc. (Sales Revenue, Cost, Gross Margin)
Table BIOPROJET Overview List
Table Narcolepsy Therapeutics Business Operation of BIOPROJET (Sales Revenue, Cost, Gross Margin)
Table BIOPROJET Overview List
Table Narcolepsy Therapeutics Business Operation of BIOPROJET (Sales Revenue, Cost, Gross Margin)
Table Shire Overview List
Table Narcolepsy Therapeutics Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
Table Ligand Pharmaceuticals, Inc. Overview List
Table Narcolepsy Therapeutics Business Operation of Ligand Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Global Narcolepsy Therapeutics Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Narcolepsy Therapeutics Sales Revenue Share, by Companies, in USD Million
Table Narcolepsy Therapeutics Demand 2012-2017, by Application, in USD Million
Table Narcolepsy Therapeutics Demand Forecast 2018-2023, by Application, in USD Million
Table Global Narcolepsy Therapeutics Market 2012-2017, by Region, in USD Million
Table Narcolepsy Therapeutics Market Forecast 2018-2023, by Region, in USD Million

LIST OF FIGURES

Figure Narcolepsy Therapeutics Industry Chain Structure
Figure Global Narcolepsy Therapeutics Market Growth 2012-2017, by Type, in USD Million
Figure Global Narcolepsy Therapeutics Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region


More Publications